glp 1 agonists addiction GLP-1 Drugs: A Game Changer for Recovery? Five things to know about
Description
GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure
Evidence is emerging that glucagon-like peptide-1 (GLP-1) receptor agonists have anti-inflammatory and chondroprotective properties independent of their effects on weight loss
The companies are working together to make it easier for companies to offer health plans that include these medications.
With an FY18 Multiple Sclerosis Research Program Investigator-Initiated Research Award, Dr
